July 29, 2016 / 11:56 AM / a year ago

BRIEF-Abbvie Q2 adjusted EPS $1.26

July 29 (Reuters) - Abbvie

* FY 2016 earnings per share view $4.75 -- Thomson Reuters I/B/E/S

* Reports Second Quarter 2016 financial results

* Q2 adjusted earnings per share $1.26

* Q2 GAAP earnings per share $0.98

* Q2 revenue $6.45 billion versus I/B/E/S view $6.2 billion

* Q2 earnings per share view $1.20 -- Thomson Reuters I/B/E/S

* Sees FY 2016 adjusted earnings per share $4.73 to $4.83

* Sees FY 2016 GAAP earnings per share $3.82 to $3.92

* Q2 total Humira sales $4,149 million versus. $3,537 million last year Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below